Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Sells 810 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the transaction, the vice president now owns 473 shares of the company’s stock, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Intuitive Surgical Trading Down 1.6 %

NASDAQ ISRG opened at $557.96 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The firm has a market cap of $198.73 billion, a PE ratio of 87.05, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The stock has a 50-day moving average of $571.08 and a 200-day moving average of $530.63.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ISRG. Howard Capital Management Group LLC increased its holdings in Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares during the period. Focus Financial Network Inc. increased its holdings in Intuitive Surgical by 14.4% during the 3rd quarter. Focus Financial Network Inc. now owns 1,273 shares of the medical equipment provider’s stock valued at $626,000 after purchasing an additional 160 shares during the period. Farther Finance Advisors LLC increased its holdings in Intuitive Surgical by 35.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,900 shares of the medical equipment provider’s stock valued at $1,425,000 after purchasing an additional 754 shares during the period. Chicago Partners Investment Group LLC increased its holdings in Intuitive Surgical by 1.4% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 2,461 shares of the medical equipment provider’s stock valued at $1,261,000 after purchasing an additional 33 shares during the period. Finally, Clear Creek Financial Management LLC increased its holdings in Intuitive Surgical by 4.4% during the 3rd quarter. Clear Creek Financial Management LLC now owns 1,551 shares of the medical equipment provider’s stock valued at $762,000 after purchasing an additional 66 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on ISRG shares. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Finally, Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.